drugset
drugset / Trial / NCT01147289

Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain

NCT01147289 ↗

Phase 3 Completed 280 enrolled Eurofarma Laboratorios S.A.
RandomizedParallel-groupOpen-labelTreatment

Summary

A phase III, randomized, multicenter, open label clinical trial to evaluate efficacy and safety of the injectable association of dexamethasone, dipyrone, and hydroxocobalamin in lumbar sciatic pain. The study will enroll 140 patients in each arm (280 total).

Timeline

Start
2011-02
Primary completion
2011-11
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 1.5 mg Intramuscular
Subject Hydroxocobalamin Unknown 5 mg Intramuscular
Comparator Meloxicam Small molecule 15 mg Intramuscular
Subject dipyrone Unknown 500 mg Intramuscular

Indications

sciatica